SGO: Reduced Opioid Use With Liposomal Bupivacaine in Surgery Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, March 30, 2016

SGO: Reduced Opioid Use With Liposomal Bupivacaine in Surgery



Medpage Today

Action Points

  • Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
  • Note that this observational study using historical controls suggested that liposomal bupivacaine may decrease subsequent opioid use among women undergoing surgery for gynecologic malignancy.

0 comments :

Post a Comment

Your comments?